Eleanor Walker, MD | Henry Ford Health ...

Dr. Eleanor M. Walker

Claim this profile

Henry Ford Hospital

Studies Prostate Adenocarcinoma
Studies Squamous Cell Carcinoma
19 reported clinical trials
60 drugs studied

Area of expertise

1Prostate Adenocarcinoma
Eleanor M. Walker has run 5 trials for Prostate Adenocarcinoma.
2Squamous Cell Carcinoma
Eleanor M. Walker has run 5 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
p16 negative
p16 positive
Stage IV

Affiliated Hospitals

Image of trial facility.
Henry Ford Hospital
Image of trial facility.
Henry Ford Macomb Hospital-Clinton Township

Clinical Trials Eleanor M. Walker is currently running

Image of trial facility.

Sentinel Lymph Node Biopsy vs Neck Dissection

for Oral Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Recruiting1 award Phase 2 & 3
Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria

More about Eleanor M. Walker

Clinical Trial Related6 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Eleanor M. Walker has experience with
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Radiation Therapy
  • Docetaxel
  • Flutamide
  • Fluorouracil

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Eleanor M. Walker specialize in?
Is Eleanor M. Walker currently recruiting for clinical trials?
Are there any treatments that Eleanor M. Walker has studied deeply?
What is the best way to schedule an appointment with Eleanor M. Walker?
What is the office address of Eleanor M. Walker?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security